[Translation] A clinical trial to evaluate the safety, tolerability and preliminary efficacy of CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection in the treatment of patients with acute-on-chronic liver failure
主要目的:评价CG-BM1治疗成人ACLF患者的安全性和耐受性,确定临床用药的安全范围。次要目的:观察CG-BM1治疗成人ACLF患者的初步有效性,为后续临床试验方案设计提供依据。
[Translation] Primary purpose: To evaluate the safety and tolerability of CG-BM1 in the treatment of adult ACLF patients and determine the safety range of clinical medication. Secondary purpose: To observe the preliminary efficacy of CG-BM1 in the treatment of adult ACLF patients and provide a basis for the design of subsequent clinical trial programs.